Upgrade to SI Premium - Free Trial

Neurocrine Bio. (NBIX) PT Raised to $131 at Baird

August 1, 2018 6:58 AM
Baird raised its price target on Neurocrine Bio. (NASDAQ: NBIX) to $131.00 (from $122.00) while maintaining an Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles